Linked Life Data

17259197

Source:http://linkedlifedata.com/resource/pubmed/id/17259197

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-3-6
pubmed:abstractText
Sean Tunis and colleagues provide an excellent critique of current federal activities to assess new medical technology. These efforts generally do not involve primary data collection but rather reflect attempts to better synthesize existing information, to make conditional coverage decisions based on the data, and to increase coordination among government agencies. Many challenges remain on analytical, logistical, legal, and political fronts. Researchers and analysts should be more precise about what "rapid learning" means and strive to measure performance. Efforts are also needed to prioritize research, to communicate it to decision-makers, to involve stakeholders in the process, and to include cost-effectiveness information.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1544-5208
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
w150-2
pubmed:meshHeading
pubmed:articleTitle
Challenges ahead for federal technology assessment.
pubmed:affiliation
Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, MA, USA. pneumann@tufts-nemc.org
pubmed:publicationType
Journal Article, Comment, Review